Antibody Investments LLC 4
4 · VACCINEX, INC. · Filed Aug 15, 2018
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Antibody Investments LLC
10% Owner
Transactions
- Conversion
Common Stock
2018-08-13+1,346,139→ 1,346,139 total - Conversion
Common Stock
2018-08-13+549,444→ 1,895,583 total - Conversion
Series C Convertible Preferred Stock
2018-08-13−7,205,882→ 0 total→ Common Stock (1,346,139 underlying) - Conversion
Series D Convertible Preferred Stock
2018-08-13−5,494,505→ 0 total→ Common Stock (549,444 underlying)
Footnotes (2)
- [F1]The reported securities converted into shares of Common Stock on a 0.1868-for-1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering.